ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ÕÅç÷¡¢ÐíÑàÍŶÓÕ¹ÏÖMettl3½éµ¼µÄm6AÐÞÊε÷¿Ø¸ÎÏËά»¯µÄлúÖÆ

¸å¼þȪԴ£º£º£ºÁ¥ÊôµÚÈýÒ½Ôº ±à¼­£º£º£ºÀîͯÖÛ¡¢Íõ¶¬Ã· ÉóºË£º£º£ºÏÄçø ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÀîÑÓÀû£©È«ÇòÔâÊܸÎÔ༲²¡Ó°ÏìµÄÉú³Ý½ü10ÒÚ £¬ £¬´øÀ´ÁËÑÏÖØµÄÉç»á¾­¼Ã¼ç¸º¡£¡£ÎÒ¹úÊǸÎÔಡ´ó¹ú £¬ £¬°üÀ¨ÂýÐÔ¸ÎÑס¢Ö¬·¾¸ÎºÍ¸ÎÓ²»¯ÔÚÄÚµÄÂýÐԸβ¡»¼Õß¿ÉÄÜ´ï4.47ÒÚÈË´Î £¬ £¬ÆäÖÐÁè¼Ý700ÍòÂýÐԸβ¡»¼Õß¿ªÕ¹µ½Á˸ÎÓ²»¯½×¶Î£¨Õ¼×ÜÉú³ÝÊý0.5%£© £¬ £¬¸Î°©»¼ÕßռȫÇòз¢ºÍéæÃü¸Î°©»¼ÕßÊýÄ¿µÄÒ»°ëÒÔÉÏ¡£¡£

ÔÚÖݪֲî±ð²¡ÒòÒýÆðµÄÂýÐԸβ¡ÖÐ £¬ £¬¸ÎÏËά»¯Êǹ²ÓеÄÏ£ÍûÀú³Ì¡£¡£ÏÖ´ú¸ÎÔಡѧµÄµÓÚ¨ÈË¡¢Òѹʸβ¡Ñ§È¨ÍþHans Popper½ÌÊÚÔøËµ£º£º£º¡°Ë­ÄÜ×èÖ¹»òÑÓ»º¸ÎÏËά»¯ £¬ £¬Ë­½«ÄÜÒ½Öδó´ó¶¼ÂýÐԸβ¡¡±¡£¡£µ«ÏÖÔÚÉÐÎÞFDA£¨ÃÀ¹úʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö£©»òCFDA£¨¹ú¼ÒʳÎïÒ©Æ·¼àÊÓÖÎÀí×ܾ֣©Åú×¼µÄ¸ÎÏËά»¯ÌØÒìÐÔÒ©Îï¡£¡£ÔõÑùÔÚ¸ÎÏËά»¯ÔçÆÚ½×¶Îʵʱ¡¢¼°Ôç¾ÙÐиÉÔ¤ £¬ £¬Äæ×ª¡¢×èÖ¹Æä½øÒ»²½¶ñ»¯ £¬ £¬ÊǸÎÔ༲²¡Ñо¿µÄÈÈÃźÍÄѵ㠣¬ £¬Ò²ÊǸÎÔ༲²¡ÖÎÁƵÄÖ÷ÒªÍ»ÆÆ¿Ú¡£¡£ÏÙÜÕËáµÚÁùλµªÔ­×ÓÉϱ¬·¢µÄ¼×»ù»¯ÐÞÊÎ(N6-methyladenosine, m6A) ÊÇÕæºËÉúÎïmRNA×î³£¼ûµÄÄÚ²¿ÐÞÊΡ£¡£m6A¼×»ù»¯ÊÇÓɼ׻ù×ªÒÆÃ¸¸´ºÏÎï(Writers)¡¢È¥¼×»ù»¯Ã¸(Erasers)ºÍÔĶÁÂѰ×(Readers)Ëù´ß»¯µÄÒ»¸ö¶¯Ì¬¿ÉÄæÐÞÊΡ£¡£m6AÏÕЩÐÞÊÎÖ§Åä×ÅRNA´úлµÄËùÓз½Ãæ(°üÀ¨mRNA¼ô½Ó¡¢ÎȹÌÐÔ¡¢·­Òë¡¢ºËÖÊÔËÊäºÍmicroRNA¼Ó¹¤µÈ) £¬ £¬ÔÚÖÖÖÖÐÄÀíºÍ²¡ÀíÀú³ÌÖÐʩչÖ÷Òª×÷Óᣡ£ÔÚ¸ÎÔàÖÐ £¬ £¬ÒÑ·¢Ã÷m6AÐÞÊμÓÈëÖ¬·¾¸Î¡¢¸ÎÔàÔÙÉú¡¢¸ÎÔàȱѪ-ÔÙ¹à×¢ËðÉË¡¢¸ÎÑײ¡¶¾Ñ¬È¾¡¢¸ÎÄÚµ¨¹Ü°©ºÍ¸Îϸ°û°©µÈÖÖÖÖ¸ÎÔ༲²¡µÄ±¬·¢¿ªÕ¹¡£¡£È»¶ø £¬ £¬m6AÐÞÊÎÔÚ¸ÎÏËά»¯Àú³ÌÖеÄ×÷ÓúÍÏêϸ»úÖÆÉв»ÇåÎú¡£¡£

¿ËÈÕ £¬ £¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÉúÎïÖÎÁÆÖÐÐÄÕÅç÷¡¢ÐíÑàÍŶÓÔÚÃÀ¹ú»ùÒòÓëϸ°ûÖÎÁÆÐ­»á£¨ASGCT£©»á¿¯Molecular TherapyÉϽÒÏþÁËÌâΪ¡°The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis¡±µÄ×îÐÂÑо¿Ð§¹û £¬ £¬Õ¹ÏÖÁËMettl3½éµ¼µÄm6AÐÞÊÎͨ¹ýHIPPO/YAPͨ·µ÷¿Ø¸ÎÐÇ״ϸ°û»î»¯ºÍ¸ÎÏËά»¯Ï£ÍûµÄй¦Ð§ £¬ £¬·¢Ã÷°ÐÏòMettl3¿ÉÒÔÓÐÓÃÒÖÖÆ¸ÎÐÇ״ϸ°ûµÄ¼¤»îºÍ¸ÎÏËά»¯Àú³Ì¡£¡£

¸ÎÐÇ״ϸ°û×÷Ϊ¸ÎÔàÌØÓеÄÒ»ÖÖ·ÇʵÖÊϸ°û £¬ £¬ÔÚ¸ÎÏËά»¯Àú³ÌÖÐʩչ×ÅÒªº¦×÷Óà £¬ £¬ÆäÔÚÕý³£×´Ì¬Ï³ʾ²Ï¢×´Ì¬ £¬ £¬µ±¸ÎÔàÊܵ½ÎïÀí¡¢»¯Ñ§ºÍ΢ÉúÎïѬȾµÈ²¡ÀíÒòËØ´Ì¼¤Ê± £¬ £¬¸ÎÐÇ״ϸ°û±»¼¤»î £¬ £¬×ª±äΪ¼¡³ÉÏËάϸ°û £¬ £¬²¢×îÏÈ´ó×ÚÔöÖ³ £¬ £¬³ÉΪϸ°ûÍâ»ùÖʵÄÖ÷ҪȪԴϸ°û¡£¡£¸ÉÔ¤¸ÎÐÇ״ϸ°ûµÄ»î»¯¡¢ÔöÖ³ºÍ´æ»îÓÐÍûÄæ×ª¸ÎÏËά»¯Àú³Ì¡£¡£Ñо¿ÍŶÓͨ¹ý¹¹½¨Lrat-Cre½éµ¼µÄ¸ÎÐÇ״ϸ°ûÌØÒìÐÔÇóým6A¼×»ù×ªÒÆÃ¸Mettl3µÄСÊó£¨Mettl3 cKOСÊó£© £¬ £¬·¢Ã÷¸ÎÐÇ״ϸ°ûÌØÒìÐÔÇóýMettl3²»Ó°ÏìСÊó·¢Óý £¬ £¬µ«ÔÚËÄÂÈ»¯Ì¼£¨CCl4£©ÓÕµ¼µÄ¸Îϸ°ûËðÉ˵¼ÖµĸÎÏËά»¯Ä£×ÓºÍDDC£¨3,5-diethoxycarbonyl-1,4-dihydro-collidine£©ÓÕµ¼µÄµ¨Ö­ÓÙ»ýµ¼ÖµÄÏËά»¯Ä£×ÓÖÐ £¬ £¬¸ÎÐÇ״ϸ°ûÌØÒìÐÔÇóýMettl3¿ÉÒÔÏÔÖø½µµÍ¸ÎËðÉËˮƽ¡¢¼õ»º¸ÎÏËά»¯Ï£Íû¡£¡£Ï¸°ûʵÑéÒ²·¢Ã÷ÇõÍ/ÇóýMettl3ÏÔÖøÒÖÖÆ¸ÎÐÇ״ϸ°ûµÄ»î»¯ºÍÏËά»¯»ùÒò±í´ï¡£¡£ÕâЩЧ¹ûÅú×¢°ÐÏòMettl3¿ÉÓÐÓÃÒÖÖÆ¸ÎÐÇ״ϸ°û»î»¯ºÍ¸ÎÏËά»¯Ï£Íû £¬ £¬½øÒ»²½µÄ»úÖÆÌ½ÌÖ֤ʵHippo/YAPÐźÅͨ·ÔÚÆäÖÐʩչ×ÅÖ÷Òª×÷Óà £¬ £¬Îª¸ÎÏËά»¯ÔçÆÚ¸ÉÔ¤ºÍÒ©ÎïÑз¢ÌṩÁËабê¡£¡£


730DAF49EAA9694DED4BF188B73_FDE2C305_11828

ͼ£º£º£ºMettl3½éµ¼µÄm6AÐÞÊε÷¿Ø¸ÎÐÇ״ϸ°û»î»¯¼°¸ÎÏËά»¯µÄ»úÖÆÊ¾Òâͼ


¸ÃÑо¿Í¨Ñ¶×÷ÕßΪÉúÎïÖÎÁÆÖÐÐÄÕÅç÷½ÌÊÚºÍÐíÑัÑо¿Ô± £¬ £¬µÚÒ»×÷ÕßΪ·Ö×Óҽѧרҵ²©Ê¿Ñо¿ÉúÀîÑÓÀûºÍ¿µÐÂ÷¡£¡£ÕÅç÷¡¢ÐíÑàÑо¿ÍŶӺã¾ÃרעÓÚ¸ÎÔ༲²¡±¬·¢¿ªÕ¹µÄ±í¹ÛÒÅ´«µ÷¿Ø»úÖÆÑо¿¼°¸ÎÔ༲²¡µÄϸ°ûÖÎÁÆÑо¿ £¬ £¬ÔÚCell Stem Cell, Journal of Hepatology, Nature Communications, Molecular TherapyµÈÔÓÖ¾½ÒÏþ¶àƪÎÄÕ £¬ £¬²¢»ñµÃ¹ú¼ÒÖØµãÑз¢ÍýÏë¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿µÈ»ù½ðÖ§³Ö¡£¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(22)00441-5


¡¾ÍøÕ¾µØÍ¼¡¿